English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduBooster vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are being promoted worldwide to counter the coronavirus disease 2019 (COVID-19) pandemic.
Tag: Vaccines
Too little sleep could make vaccination less effective
Sleeping fewer than six hours per night around the time of vaccination was associated with a robust decrease in antibody response, researchers found.
Education levels impact on belief in scientific misinformation and mistrust of COVID-19 preventive measures
A new study has found that people with a university degree were less likely to believe in COVID-19 misinformation and more likely to trust preventive measures than those without a degree.
LLNL Biomedical Licensee Collaborating With Two Drug Companies To Advance Treatments For Autoimmune Diseases
People afflicted with autoimmune diseases may someday receive help through treatments now under development by a Lawrence Livermore National Laboratory (LLNL) licensee and its’ collaborations with two major pharmaceutical companies.
Breakthrough COVID-19 cases occur in 7.5% of vaccinated Texas participants, according to UTHealth Houston survey; subgroups at higher risk identified
Breakthrough COVID-19 infections after vaccination occurred in 7.5% of Texans surveyed and were linked to Hispanic ethnicity, larger household size, rural versus urban living, type of vaccination, and multiple comorbidities, according to findings from UTHealth Houston School of Public Health published today in the Journal of Infectious Diseases.
Artificial Intelligence Aids Discovery of Super Tight-Binding Antibodies
UC San Diego scientists developed an artificial intelligence tool that could accelerate the development of new high affinity antibody drugs.
Two UCI researchers named fellows by the National Academy of Inventors
Irvine, Calif., Dec. 8, 2022 — The National Academy of Inventors has named two University of California, Irvine researchers as fellows for 2022. Philip Felgner, a pioneer in the development of lifesaving mRNA vaccines, and Payam Heydari, a prolific creator of cutting-edge microelectronics technologies, were both recognized for inventions that have made tangible impact on quality of life, economic development and the welfare of society.
Study reveals vaccine confidence declined considerably during COVID-19 pandemic
Researchers comparing pre and post-pandemic surveys have found confidence in vaccinations is considerably lower post pandemic amongst all demographic groups.
Study: Concerns over COVID-19 vaccine’s effectiveness, not general medical mistrust, slowed early uptake in Black, Latinx communities
New research on COVID-19 vaccine hesitancy in Black, Latinx communities could help shape more persuasive messages to boost uptake.
Needs and Challenges for COVID-19 Boosters and Other Vaccines in the U.S.
FAU researchers and collaborators provide the most updated guidance to health care providers and urge how widespread vaccination with these boosters can now avoid the specter of future and more lethal variants becoming a reality.
Cancer Patients Treated with Immunotherapy Can Safely Receive mRNA COVID-19 Vaccines, According to JNCCN Study
New research published in the October 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms the safety of mRNA vaccines in people with cancer undergoing immunotherapy treatment.
Risk of Severe Breakthrough COVID-19 Infection Is Higher for People With HIV With Moderately Low CD4 Cell Counts
People with HIV who have moderate immune suppression appear to be at greater risk of severe COVID-19 “breakthrough” infection after vaccination, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
University Hospitals Chosen as Site for United States Flu Vaccine Effectiveness Network
The Center for Disease Control’s National Center for Immunization and Respiratory Diseases has awarded University Hospitals of Cleveland a sizable grant to support its assignment as a study site in the United States Flu Vaccine Effectiveness Network.
Pregnant Women of Lower Socioeconomic Status More Likely to Have Vaccine Hesitancy
A published study of 1,899 pregnant women nationwide representing all 50 states reveals that during the Covid-19 pandemic if a pregnant woman had lower socioeconomic status and/or were African American, she was less likely to have the intention of taking a Covid-19 vaccine or actually receiving it.
COVID mRNA vaccines are safe in patients with heart failure
COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure, according to research presented at ESC Congress 2022.
Mount Sinai Announces the Formation of CastleVax Inc., a Clinical-Stage Infectious Diseases Company Developing Novel Vaccines and Therapeutics, Targeting Pandemic Threats and Diseases of Unmet Medical Need
The Mount Sinai Health System has launched CastleVax, Inc. (“CastleVax”), a clinical-stage vaccine research and development company.
Disparities in United States COVID-19 Vaccine Distribution
Health care facilities in Black metropolitan counties, Hispanic rural counties and hardest-hit counties were less likely to administer COVID-19 vaccines during initial rollout, UC San Diego study finds.
COVID vaccines averted infection in 10% of patient-facing healthcare staff during second wave
The rapid covid-19 vaccine rollout from December 2020 averted infection in a large proportion of NHS hospital workers in England during the second wave of the pandemic, suggests research published by The BMJ today.
Familiarity Breeds Exempt: Why Staph Vaccines Don’t Work in Humans
UC San Diego researchers say they may have found the reason why multiple human clinical trials of staphylococcus vaccines have failed: the bacteria knows us too well.
Immune Molecules From a Llama Could Provide Protection Against a Vast Array of SARS-like Viruses Including COVID-19, Researchers Say
Mount Sinai-led researchers have shown that tiny, robust immune particles derived from the blood of a llama could provide strong protection against every COVID-19 variant, including Omicron, and 18 similar viruses.
Researchers Continue Study of COVID-19 Vaccinations, Pregnancy and Postpartum
A $10 million grant over four years will support further examination of a national study looking at COVID-19 vaccination safety during pregnancy and immune response pre-and post-delivery for both mom and baby.
University of Pennsylvania’s First NFT Commemorates mRNA Research
The historic scientific breakthrough at the Perelman School of Medicine at the University of Pennsylvania that helped lead the world’s fight against COVID-19 through mRNA-based vaccines is being commemorated through a non-fungible token—a digital asset to be auctioned by Christie’s—that will support ongoing research at Penn.
SEIR Model to Address the Impact of Face Masks amid COVID-19 Pandemic
When vaccines are not available, alternative strategies are required to decrease SARS-CoV-2 transmission. Behavior of the population and government regulations, such as hand hygiene, quarantine of exposed persons, isolation of symptomatic persons, and travel restriction, play an essential role in…
Gene Sequencing an Important Tool in COVID-19 Battle
Researchers use gene sequencing to combat COVID-19.
The US reaches 1 Million Deaths from COVID-19: GW Experts Available to Comment
The United States has reached 1 million reported deaths from COVID-19 and that number is likely an undercount, according to the Centers for Disease Control and Prevention. The George Washington University has a number of experts to comment on the…
2022 Warren Alpert Prize goes to mRNA research that enabled the design of COVID-19 vaccines
The work of the award recipients altered the trajectory of the pandemic and has saved countless lives
The discoveries made by the five scientists have opened the door for an array of mRNA-based therapies and vaccines for a range of diseases, including cancer, heart disease, bleeding disorders, and more
UCI professor wins prestigious Robert Koch Prize for groundbreaking research
Irvine, Calif., April 27, 2022 – Philip Felgner, Ph.D., professor in residence of physiology & biophysics at the University of California, Irvine, is one of two scholars to win the prestigious 2022 Robert Koch Prize for fundamental contributions to the transfer of nucleic acids into cells. This pioneering technology for treating infectious diseases played a crucial role in developing the messenger RNA COVID-19 vaccines.
Age, sex and waning COVID-19 antibodies
As widely-anticipated decisions about COVID-19 vaccine boosters roll out from U.S. agencies today, insights from an independent study underscore why boosters are important for all adults.
Genome sequencing reveals widespread COVID-19 infection in white-tailed deer
Houston Methodist’s SARS-CoV-2 genome sequencing team has partnered on a study led by Penn State that revealed 80% of white-tailed deer sampled across Iowa at the height of the 2020-2021 deer-hunting season tested positive for the SARS-CoV-2 virus. Analysis of the virus genome sequences revealed infections were likely the result of multiple human-to-deer transmission “spillover” events followed by deer-to-deer transmission from April 2020 through January 2021.
Confusion, frustration await foreign travelers to US
As the U.S. reopens international borders to foreign travelers, airlines are bracing for congestion as the new rules are rolled out – this in addition to staffing issues that have caused operation complications for some carriers recently. Arthur Wheaton, an expert…
Expert Alert: 5 ways patients who are immunocompromised can protect themselves from COVID-19
As families prepare to gather later this month for Thanksgiving, it is important for patients who are immunocompromised to take extra steps to protect themselves from becoming infected with COVID-19. People who are immunocompromised have weakened immune systems, which means they have a higher risk of becoming severely ill from COVID-19.
FAU Expert Answers Questions about Boosters, Vaccines for Children Ages 5-11
Joanna Drowos, D.O., M.P.H., M.B.A., FAU Schmidt College of Medicine, provides answers to some of the most frequently asked questions regarding the COVID-19 boosters and vaccines for children ages 5 to 11.
Morgridge invites experts to discuss COVID-19 vaccines for kids in upcoming speaker series
The Morgridge Institute for Research will broadcast a free webinar on November 9, featuring a conversation with experts on the front lines of pediatric vaccine development and public health.
Patients taking Rituximab Could Benefit from Third COVID-19 Vaccine Dose
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows patients using rituximab were able to produce antibodies against COVID-19 after receiving a third vaccine dose, even if there was no development of the antibody after the first two.
Nearly One Third of Lupus Patients in One Study Had Low Responses to COVID-19 Vaccines
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that nearly 30% of patients with lupus in a multi-ethnic and multi-racial study had a low response to the new COVID-19 vaccines.
Study Finds COVID-19 Vaccine Not Associated with Severe Disease Flare in Patients with Rheumatic Diseases
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that the COVID-19 vaccine was not associated with severe disease flares in patients with rheumatic diseases.
Studies reveal what makes the Delta variant so infectious
The Delta variant of SARS-CoV-2 has swept the globe, becoming the dominant variant within just a few months.
Study supports safety of COVID-19 vaccines in people with a history of severe allergic reactions
New research addresses ongoing concerns regarding risks of allergic reactions after receiving mRNA COVID-19 vaccines, particularly for individuals with a history of severe allergic reactions.
Rutgers Expert Available to Discuss Mixing and Matching of COVID-19 Vaccines, Booster Shots
Rutgers infectious disease expert Shobha Swaminathan is available to discuss the mixing and matching of COVID-19 vaccines and boosters as the Food and Drugs Administration authorized booster shots for both the Johnson & Johnson and Moderna vaccines. “There is mounting…
Vaccines offer strong protection against death from Delta, study says
Vaccination is over 90 per cent effective at preventing deaths from the Delta variant of Covid-19, according to the first country-level data on mortality.
LLNL joins Human Vaccines Project to accelerate vaccine development and understanding of immune response
Lawrence Livermore National Laboratory has joined the international Human Vaccines Project, bringing Lab expertise and computing resources to the consortium to aid development of a universal coronavirus vaccine and improve understanding of immune response.
Hopkins Med News Update
Hopkins Med News Update
Grow and eat your own vaccines?
The future of vaccines may look more like eating a salad than getting a shot in the arm.
American University Experts Available to Discuss Misinformation’s Impacts
What: As misinformation continues to spread and proliferate online impacting our daily lives, the topics and issues affected range from vaccines, COVID, conspiracy theories, and the 2020 election. American University scholars are available to share their insights on a broad…
Looking at the Legal Ins and Outs of Vaccine Mandates
Johns Hopkins Carey Business School Associate Professor Stacey Lee, an expert in business law, health law, and negotiation, addresses some of questions raised by President Biden’s recent plans for increasing COVID-19 vaccinations.
Johns Hopkins Center for Communication Programs Launches Comprehensive Global COVID Behavior Dashboard
A new dashboard launched by the Johns Hopkins Center for Communication Programs unpacks survey findings and helps explain why some people say they definitely or probably won’t get a COVID-19 vaccine.
Study: No Serious COVID-19 Vaccine Side Effects in Breastfeeding Moms, Infants
Researchers found that breastfeeding mothers who received either the Pfizer-BioNTech or Moderna vaccination reported the same local or systemic symptoms as what has been previously reported in non-breastfeeding women, with no serious side effects in the breastfed infants.
FIELDING FOCUS | Covid-19 Conversation: Navigating Variants, Vaccines & Boosters
In this session, panelists Dr. Robert Kim-Farley (professor, departments of Epidemiology & Community Health Sciences) and Dr. Anne Rimoin (professor, Department of Epidemiology & director, Center for Global and Immigrant Health) will discuss the latest news on the pandemic in a conversation moderated by Dr. Ron Brookmeyer, dean of the UCLA Fielding School of Public Health & distinguished professor, Department of Biostatistics.
With Time and Without Masks, COVID-19 Vaccines Wane in Protection
A study measured effectiveness of COVID-19 mRNA vaccines among health workers, most notably during the emergence of delta virus variant and coincident with end of state’s mask mandate, finding protection waned over time, dropping sharply 6-8 months after full vaccination.
2VIDA! Tackles COVID Vaccine Hesitancy and Barriers in Latinx, Black Communities
UC San Diego is collaborating with San Ysidro Health on an NIH-funded outreach program to address COVID-19 vaccine hesitancy in Latinx and African American communities. The team runs pop-up vaccination sites across San Diego, and goes door-to-door to homes and local businesses to spread awareness.